Canada markets closed

Immuneering Corporation (IMRX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.6400+0.0800 (+5.13%)
At close: 04:00PM EDT
1.7300 +0.09 (+5.49%)
After hours: 07:24PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 48.63M
Enterprise Value -32.57M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)563.62
Price/Book (mrq)0.54
Enterprise Value/Revenue 191.91k
Enterprise Value/EBITDA 0.56

Trading Information

Stock Price History

Beta (5Y Monthly) -0.89
52-Week Change 3-78.45%
S&P500 52-Week Change 322.38%
52 Week High 311.9200
52 Week Low 31.3800
50-Day Moving Average 33.3583
200-Day Moving Average 36.3896

Share Statistics

Avg Vol (3 month) 3755k
Avg Vol (10 day) 3476.43k
Shares Outstanding 529.65M
Implied Shares Outstanding 629.65M
Float 817M
% Held by Insiders 129.18%
% Held by Institutions 138.03%
Shares Short (Apr 15, 2024) 42.73M
Short Ratio (Apr 15, 2024) 41.75
Short % of Float (Apr 15, 2024) 417.41%
Short % of Shares Outstanding (Apr 15, 2024) 49.32%
Shares Short (prior month Mar 15, 2024) 42.61M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-32.46%
Return on Equity (ttm)-53.36%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -58.06M
Net Income Avi to Common (ttm)-53.47M
Diluted EPS (ttm)-1.8800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)85.67M
Total Cash Per Share (mrq)2.92
Total Debt (mrq)4.46M
Total Debt/Equity (mrq)4.93%
Current Ratio (mrq)11.35
Book Value Per Share (mrq)3.09

Cash Flow Statement

Operating Cash Flow (ttm)-48.97M
Levered Free Cash Flow (ttm)-31.1M